Acadia Pharmaceuticals (ACAD) just stacked two key clinical milestones: a fresh USPTO Notice of Allowance extending potential ...

Investment firm RBC said the patent litigation between Acadia Pharmaceuticals (ACAD) and generic drugmaker Zydus over Nuplazid appears to have been resolved. Shares of Acadia Pharmaceuticals turned ...

Here is how Acadia Healthcare (ACHC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this ...

Acadia Healthcare trades at $28.83 and has moved in lockstep with the market. Its shares have returned 13.5% over the last ...

Acadia Pharmaceuticals ( ACAD) sank almost 7% on Friday, closing at $20.68 after a drop of $1.50. This came after a 13% drop ...

While Acadia Pharmaceuticals’ candidate has missed the main goal of a Phase 2 trial, the company is still moving forward with the anti-psychosis candidate in Alzheimer’s disease as well as Lewy body ...

Acadia Pharmaceuticals’ phase 2 Alzheimer’s disease trial has missed its primary endpoint, but the company and analysts alike ...

Acadia Pharmaceuticals (ACAD) stock slides as a mid-stage trial for the company's Alzheimer’s psychosis therapy fails. Read more here..

We bought a 2024 GMC Acadia Elevation AWD for $49,190—anonymously from an area dealer, as we do with every vehicle we test—for the purpose of this road test review. The Acadia is assembled in Lansing, ...